Immediate Impact
50 standout
Citing Papers
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Works of Luis Robles being referenced
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer
2018
Regorafenib as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients with metastatic colorectal cancer (mCRC): A study of the Spanish Cooperative Group for digestive tumor therapy (TTD).
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Luis Robles | 227 | 93 | 71 | 32 | 319 | |
| Brenda K. Shelton | 154 | 101 | 57 | 28 | 358 | |
| U. Mueller | 112 | 84 | 34 | 32 | 270 | |
| Anca Zgură | 137 | 65 | 24 | 45 | 371 | |
| Jiann-Shiuh Chen | 51 | 94 | 34 | 23 | 346 | |
| Ajay Gupta | 123 | 48 | 14 | 23 | 295 | |
| Arnaud Ferraris | 55 | 85 | 49 | 25 | 341 | |
| Tsutomu Takahashi | 105 | 38 | 68 | 35 | 317 | |
| C. I. Backhouse | 99 | 52 | 64 | 30 | 367 | |
| I Koza | 187 | 100 | 16 | 37 | 332 | |
| Charlene M. McShane | 67 | 81 | 28 | 26 | 314 |
All Works
Login with ORCID to disown or claim papers
Loading papers...